Scinai Immunotherapeutics Secures $2.61 Million Financing for CDMO Expansion
Scinai Immunotherapeutics Ltd. has secured $2.61 million in funding via a private placement. This capital will support the expansion of their Contract Development and Manufacturing Organization (CDMO) and facilitate growth in customer programs, impacting future operations and market positioning.
View signal analysis